OR WAIT 15 SECS
Malvern Instruments Acquires Viscotek Corporation; Thermo Fisher Scientific Wins 2007 Frost and Sullivan Award; The Kinesis Group Acquires Abimed Analysen
Malvern Instruments Acquires Viscotek Corporation
Malvern Instruments (UK), a materials characterization company, announced its acquisition of Viscotek Corporation, a leading provider of chromatography solutions for the characterization of natural and synthetic polymers and proteins. Viscotek will bring new and complementary technologies and expertise to Malvern, adding gel permeation chromatography (GPC), flow injection polymer analysis (FIPA) and dilute solution viscosity (DSV), and extending the range of characterization solutions offered.
Viscotek Corporation, based in Houston, Texas, was founded in 1984 by Dr. Max Haney, inventor of the four-capillary differential viscometer detector. According to Paul Walker, Malvern's managing director, the alignment of Viscotek's products with Malvern's range will provide even more opportunity to comprehensively meet a broad range of customer needs. Viscotek's present management will continue to lead the business, which will operate as Viscotek Corporation, a Malvern Company.
Thermo Fisher Scientific Wins 2007 Frost & Sullivan Award
Thermo Fisher Scientific, Inc. (Waltham, Massachusetts) has been honored with the 2007 Frost & Sullivan Market Leadership Award for its outstanding contribution to the US High Content Screening (HCS) market. This award credits the company's expertise, insight into customer requirements, and technological innovation and advanced solutions for cell-based screening and analysis. Frost & Sullivan has identified Thermo Fisher as excellent in all areas of market leadership due to their ability to monitor market changes and implement strategies to meet the rapidly changing industry demands.
The Kinesis Group Acquires Abimed Analysen
The Kinesis group of companies (UK) announced its acquisition of Abimed Analysen, a German-based company focused on the chromatography and liquid handling markets.
According to the company, the acquisition of Abimed will provide the Kinesis group with an excellent platform to penetrate Europe's largest market.